MetaADEDB 2.0 @ LMMD
Proctosedyl
(AZXZMCQMDWVCDF-SCEXVKQTSA-N)
Structure
SMILES
OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C.OC[C@H]1O[C@H]([C@@H]([C@@H]1O[C@H]1O[C@@H](CN)[C@H]([C@@H]([C@H]1N)O)O)O)O[C@@H]1[C@@H](O)[C@H](N)C[C@@H]([C@H]1O[C@H]1O[C@H](CN)[C@H]([C@@H]([C@H]1N)O)O)N.CCCCOc1nc2ccccc2c(c1)C(=O)NCCN(CC)CC
Molecular Formula:
C64H105N9O20
Molecular Weight:
1320.570
Log P:
0.9643
Hydrogen Bond Acceptor:
29
Hydrogen Bond Donor:
17
TPSA:
502.4
CAS Number(s):
8058-05-7
Synonym(s)
1.
Proctosedyl
2.
Proctosedyl ointment
3.
Proctosedyl suppository
External Link(s)
MeSHC056407
PubChem Compound165678
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainCanada Vigilance: 1Canada Vigilance
2Accidental overdoseCanada Vigilance: 1Canada Vigilance
3Cold sweatCanada Vigilance: 1Canada Vigilance
4DermatitisCanada Vigilance: 1Canada Vigilance
5Drug ineffectiveCanada Vigilance: 2Canada Vigilance
6ErythemaCanada Vigilance: 1Canada Vigilance
7HeadacheCanada Vigilance: 1Canada Vigilance
8HypersensitivityCanada Vigilance: 1Canada Vigilance
9InflammationCanada Vigilance: 1Canada Vigilance
10PainCanada Vigilance: 2Canada Vigilance
11Product packaging issueCanada Vigilance: 1Canada Vigilance
12Product physical issueCanada Vigilance: 1Canada Vigilance
13PruritusCanada Vigilance: 2Canada Vigilance
14Rash erythematousCanada Vigilance: 1Canada Vigilance
15Rectal dischargeCanada Vigilance: 1Canada Vigilance
16RestlessnessCanada Vigilance: 1Canada Vigilance
17TensionCanada Vigilance: 1Canada Vigilance
18Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.